In a randomized, double-blind and controlled trial, 90 patients supplemented with Que twice daily for 12 weeks showed significantly higher erythrocyte levels but evidently lower mean erythrocyte volume and hemoglobin, as well as ferritin compared to controls (77)
As a dual GLP-1 and GIP receptor agonist, Tirzepatide affects multiple pathways simultaneously: It slows gastric emptying, enhances insulin secretion in a glucose-dependent manner, suppresses glucagon secretion, and powerfully suppresses appetite
KPV research examines the peptide's effects on collagen organization patterns through inflammatory pathway modulation
[73] [74] [75] It is synthesized by some bacteria in the gut microbiota in humans and other animals, but it has long been thought that humans cannot absorb this as it is made in the colon, downstream from the small intestine, where the absorption of most nutrients occurs